Sreedevi Vayalapalli is a Psychiatry physician. OpenAlex indexes 18 publications with 698 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
950 Scales Rd Ste 302
Suwanee, GA 300244342
Telephone
404-994-5000Provider last certified this registry record 8 Apr 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teva Pharmaceuticals USA, Inc.Program year20252 payments
- ABBVIE INC.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
99%Atypical Antipsychotic28.1%Quetiapine Fumarate48%Aripiprazole20%Risperidone18%Olanzapine7%Invega Sustenna4%Latuda2%Paliperidone Er2%Part D<11 patientsSSRI26.7%Trazodone Hcl37%Sertraline Hcl23%Fluoxetine Hcl22%Escitalopram Oxalate11%Citalopram Hbr8%Part D<11 patients+ 17 more classes in this area
Cardiovascular
1%Central alpha-2 Adrenergic Agonist1%Clonidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of QTc Interval Prolongation for Patients in Methadone Versus Buprenorphine Maintenance Treatment: A 5-Year Follow-Up
Journal of Addictive Diseases
2013 - QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study
The American Journal of Drug and Alcohol Abuse
2013 - Predictors of Diabetes Mellitus and Abnormal Blood Glucose in Patients Receiving Opioid Maintenance Treatment
American Journal on Addictions
2013 - Effect of Buprenorphine on Liver Function Tests for Patients Undergoing Long-term Maintenance Treatment
Addictive Disorders & Their Treatment
2013 - Predictors of Substance Abuse Treatment Outcome in Hospitalized Veterans
American Journal on Addictions
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”